On Demand 2018 ACAAI Annual Meeting: General Sessions

Cost: $345 for College members, $425 for non-members.

You can earn up to 63 AMA PRA Category 1 Credits™, and up to a maximum of 12 MOC Part II Self-Assessment credits. This collection covers general sessions from Thursday, Friday, Saturday, Sunday, and Monday's program; including, plenaries, symposia, and the Thursday Program.

Release Date: 11/20/2018
Expiration Date: 11/19/2021

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 63 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Of the AMA PRA Category 1 Credits™ listed above, the ABAI has designated a maximum of 12 credits as meeting the requirements for MOC Part II Self-Assessment.

Target Audience

Medical professionals who treat patients with allergic and/or immunological conditions:

Practicing allergist/immunologists
Allergy/immunology Fellows-in-Training
Physician assistants
Nurses and advanced practice nurses
Allied health professionals
Primary care physicians
Other medical professionals

Learning Objectives

At the conclusion of this activity, participants should be able to:

Identify major advances in key areas of cutting edge research in immunologic mechanisms and allergic responses, including anaphylaxis and pathophysiology of the upper airways, lungs, eyes, skin and gastrointestinal tract.
Demonstrate knowledge of basic processes linking molecular and cellular biology and genetics with allergic pathophysiology and immunodeficiency.
Translate emerging clinical science principles to clinical practice in patients with allergic and immunologic diseases.
Evaluate and implement state-of-the-art diagnostic and therapeutic strategies for treating patients with allergic and immunologic diseases.
Explain the impact of environmental exposures and external influences on patients with allergic disorders.
Recognize emerging trends in the prevalence of allergic and immunologic disorders and discuss their impact on public health.
Evaluate the impact of new diagnostic and therapeutic strategies on health care costs and outcomes.
Discuss processes, tools and technologies for the efficient allergy and immunology practice.

Additional information

Disclosure:

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (College) policy, the College must identify and resolve conflicts of interest for all individuals responsible for the development, management, presentation, or evaluation of content for a CME activity. Financial disclosures are reviewed in advance, to ensure any potential conflicts of interest are resolved. Disclosure in no way implies that the information presented is biased or of lesser quality; it is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Specific disclosure information for the 2018 Annual Meeting is conveniently located online

Course summary

Available credit: